Sangyong Jon

Sangyong Jon

KAIST

H-index: 70

Asia-South Korea

About Sangyong Jon

Sangyong Jon, With an exceptional h-index of 70 and a recent h-index of 46 (since 2020), a distinguished researcher at KAIST, specializes in the field of Nanomedicine, Drug Delivery, Biologics, Immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long‐Term Immune Memory by Reprogramming Tumor‐Associated Macrophages (Adv. Healthcare …

Particles comprising bilirubin derivative and metal

Prodrug Celecoxib‐Derived Nanoparticles Potentiate the Efficacy of Cancer Immunotherapy by Remodeling the Tumor Microenvironment

Glycocalyx‐Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy

Bilirubin nanoparticle, use thereof, and preparation method therefor

Longitudinal Magnetic Resonance Imaging with ROS‐Responsive Bilirubin Nanoparticles Enables Monitoring of Nonalcoholic Steatohepatitis Progression to Cirrhosis

1337 Bilirubin nanomedicine alleviates inflammation and angiogenesis in a rosacea mouse model

Anti‐inflammatory glycocalyx‐mimicking nanoparticles for colitis treatment: construction and in vivo evaluation

Sangyong Jon Information

University

Position

Full Professor of Department of Biological Sciences

Citations(all)

22591

Citations(since 2020)

7843

Cited By

18099

hIndex(all)

70

hIndex(since 2020)

46

i10Index(all)

172

i10Index(since 2020)

134

Email

University Profile Page

KAIST

Google Scholar

View Google Scholar Profile

Sangyong Jon Skills & Research Interests

Nanomedicine

Drug Delivery

Biologics

Immunotherapy

Top articles of Sangyong Jon

Title

Journal

Author(s)

Publication Date

Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long‐Term Immune Memory by Reprogramming Tumor‐Associated Macrophages (Adv. Healthcare …

Advanced Healthcare Materials

Yujin Kim

Seojung Lee

Sangyong Jon

2024/3

Particles comprising bilirubin derivative and metal

2024/2/13

Prodrug Celecoxib‐Derived Nanoparticles Potentiate the Efficacy of Cancer Immunotherapy by Remodeling the Tumor Microenvironment

Advanced Therapeutics

Tae Woo Kim

Chang‐Hee Whang

Dohyeon Kim

Sangyong Jon

2024/1/21

Glycocalyx‐Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy

Advanced Materials

Dohyeon Kim

Chang‐Hee Whang

Jungwoo Hong

Monica Celine Prayogo

Wonsik Jung

...

2024/3/15

Bilirubin nanoparticle, use thereof, and preparation method therefor

2024/2/20

Longitudinal Magnetic Resonance Imaging with ROS‐Responsive Bilirubin Nanoparticles Enables Monitoring of Nonalcoholic Steatohepatitis Progression to Cirrhosis

Advanced Materials

Wonsik Jung

Muhammad Asaduddin

Hyeongseop Keum

Youngju Son

Dohyun Yoo

...

2024/3/9

1337 Bilirubin nanomedicine alleviates inflammation and angiogenesis in a rosacea mouse model

Journal of Investigative Dermatology

C Choi

B Kang

H Keum

S Yang

D Kim

...

2023/5/1

Anti‐inflammatory glycocalyx‐mimicking nanoparticles for colitis treatment: construction and in vivo evaluation

Angewandte Chemie

Dohyun Yoo

Chang‐Hee Whang

Jungwoo Hong

Dohyeon Kim

Monica Celine Prayogo

...

2023/8/21

Liquid-phase-based cell culture platform that enables polymer surface stimuli-induced generation of patient-specific glioma stem cell-like tumor spheroids

Cancer Research

Junhyuk Song

Yoonjung Choi

Yumi Lee

Hyo E Moon

Changjin Seo

...

2023/4/4

Bilirubin nanomedicine alleviates inflammation and angiogenesis in a rosacea mouse model

Advanced Therapeutics

Chong Won Choi

Hyeongseop Keum

Seoyun Yang

Bo Mi Kang

Dohyeon Kim

...

2023/4

Fusion protein comprising bp26 and antigenic polypeptide

2023/8/17

Bilirubin derivative-based diagnostic and therapeutic ultrasound contrast agent

2023/2/7

Bilirubin nanomedicine rescues intestinal barrier destruction and restores mucosal immunity in colitis

ACS nano

Afia Tasnim Rahman

Jongoh Shin

Chang-Hee Whang

Wonsik Jung

Dohyun Yoo

...

2023/5/25

Particles including chitosan-bilirubin conjugate, and oral pharmaceutical composition including same

2023/11/9

Nanovaccine displaying immunodominant T cell epitopes of fibroblast activation protein is effective against desmoplastic tumors

ACS nano

Hocheol Shin

Yujin Kim

Sangyong Jon

2023/5/15

Impact of media compositions and culture systems on the immunophenotypes of patient-derived breast cancer cells

BMC cancer

Seungyeon Ryu

So-Hyun Yoon

Junhyuk Song

Yoonjung Choi

Sangeun Lee

...

2023/9/6

Nanoparticles derived from naturally occurring metal chelators for theranostic applications

Wonsik Jung

Dong Yun Lee

Eugene Moon

Sangyong Jon

2022/12/1

Photomedicine based on heme-derived compounds

Hyeongseop Keum

Dohyun Yoo

Sangyong Jon

2022/3/1

Spheroid culture of ER+ breast cancer patient-derived tumor cells enriches cancer stem-likecells with EpCAM-/CD49f+ and high ALDH activity and poor prognostic gene signatures

Cancer Research

Hoe Suk Kim

Seungyeon Ryu

So-Hyun Yoon

Sangeun Lee

Junhyuk Song

...

2022/6/15

Abstract P5-12-11: NSDHL knockdown decreases tightly cohesive tumorsphere formation and breast cancer stem cell population

Cancer Research

So-Hyun Yoon

Hoe Suk Kim

Junhyuk Song

Sunkyu Kwon

Seungyeon Ryu

...

2022/2/15

See List of Professors in Sangyong Jon University(KAIST)